Perspective Therapeutics, Inc. (CATX) Earnings
|
Expand Research on CATX
| Next EPS Date | 11/17/26 | EPS Growth Rate | +31.4% |
|---|---|---|---|
| Average EPS % Beat Rate | +5.7% | Revenue Growth Rate | -73.1% |
| Average % Move 1-Wk after EPS | -2.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/17/26  |
Q326 | N/A | -$0.24 | N/A | N/A | $78.04K | N/A | N/A | N/A | ||
| 8/10/26 |
Q226 | -$0.22 | -$0.26 | +$0.04 | $80K | $90.53K | N/A |  | | Details | |
| 5/11/26 | Q126 | -$0.25 | -$0.30 | +$0.05 | $76K | $157.38K | N/A | | | Details | |
| 3/26/26 |
Q425 | N/A | -$0.35 | N/A | N/A | $230.65K | N/A | N/A | N/A | ||
| 11/10/25 |
Q325 | -$0.35 | -$0.32 | -$0.03 | $290K | $224.08K | N/A | | | Details | |
| 8/13/25 |
Q225 | -$0.29 | -$0.29 | $0.00 | $290K | $185.86K | N/A | | | Details | |
| 8/8/25 |
Q225 | N/A | -$0.29 | N/A | N/A | $185.86K | N/A | N/A | N/A | ||
| 5/13/25 |
Q125 | -$0.25 | -$0.31 | +$0.06 | N/A | $134.48K | N/A | | | Details |
